Cargando…

The role of CD180 in hematological malignancies and inflammatory disorders

Toll-like receptors play a significant role in the innate immune system and are also involved in the pathophysiology of many different diseases. Over the past 35 years, there have been a growing number of publications exploring the role of the orphan toll-like receptor, CD180. We therefore set out t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edwards, Kurtis, Lydyard, Peter M., Kulikova, Nino, Tsertsvadze, Tamar, Volpi, Emanuela V., Chiorazzi, Nicholas, Porakishvili, Nino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353253/ https://www.ncbi.nlm.nih.gov/pubmed/37460961 http://dx.doi.org/10.1186/s10020-023-00682-x

Ejemplares similares

Role of CD47 in Hematological Malignancies
por: Eladl, Entsar, et al.
Publicado: (2020)

Synthesis, Characterization, and In Vitro Cytotoxicity Evaluation of Doxorubicin-Loaded Magnetite Nanoparticles on Triple-Negative Breast Cancer Cell Lines
por: Markhulia, Jano, et al.
Publicado: (2023)

Hematologic Findings in Pregnancy: A Guide for the Internist
por: Patel, Pooja, et al.
Publicado: (2021)

Molecular Aspects of Hematological Malignancies and Benign Hematological Disorders
por: Găman, Amelia Maria
Publicado: (2023)

CD markers polymorphisms as prognostic biomarkers in hematological malignancies
por: Shahrabi, Saeid, et al.
Publicado: (2020)

Targeting CD22 for B-cell hematologic malignancies
por: Xu, Jia, et al.
Publicado: (2023)

New Bacteriophages with Podoviridal Morphotypes Active against Yersinia pestis: Characterization and Application Potential
por: Suladze, Tamar, et al.
Publicado: (2023)

Safety of bronchoscopy in patients with malignant hematologic disorders
por: Uruga, Hironori, et al.
Publicado: (2020)

The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy
por: Jiang, Xuan, et al.
Publicado: (2023)

Monoclonal antibodies targeting CD38 in hematological malignancies and beyond
por: van de Donk, Niels W. C. J., et al.
Publicado: (2016)

CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies
por: Testa, Ugo, et al.
Publicado: (2019)

The landscape overview of CD47-based immunotherapy for hematological malignancies
por: Yang, Hua, et al.
Publicado: (2023)

Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic Malignancies
por: Testa, Ugo, et al.
Publicado: (2022)

Insomnia, Pre-Sleep Arousal, Psychosocial Factors and Changes in Sleep Pattern during the Second Wave Lockdown of the COVID-19 Pandemic in Georgia
por: Basishvili, Tamar, et al.
Publicado: (2021)

Feasibly of CD24/CD11b as a Screening Test for Hematological Malignancies
por: Shapira, Shiran, et al.
Publicado: (2021)

Patterns of Bone Marrow Confirmed Malignant and Non-Malignant Hematological Disorders in Patients with Abnormal Hematological Parameters in Northeast Ethiopia
por: Ebrahim, Hussen, et al.
Publicado: (2022)

SUN-180 A Case of Deoxycorticosterone-Producing Malignant Adrenocortical Tumor
por: Cartolano, Natasha Scaranello, et al.
Publicado: (2020)

Delayed recurrence of an iridociliary malignant melanoma 180° from the primary tumor
por: Hopkins, Nikolas S., et al.
Publicado: (2022)

Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies
por: Bartlett, Nancy L, et al.
Publicado: (2014)

Engineering naturally occurring CD7(−) T cells for the immunotherapy of hematological malignancies
por: Freiwan, Abdullah, et al.
Publicado: (2022)

Expanding role of lenalidomide in hematologic malignancies
por: Ghosh, Nilanjan, et al.
Publicado: (2015)

Role of Extracellular Vesicles in Hematological Malignancies
por: Raimondo, Stefania, et al.
Publicado: (2015)

Multiple Roles of Glycans in Hematological Malignancies
por: Pang, Xingchen, et al.
Publicado: (2018)

Role of circular RNA in hematological malignancies
por: Mei, Mei, et al.
Publicado: (2019)

Update on the role of copanlisib in hematologic malignancies
por: Le, Thuy, et al.
Publicado: (2021)

Role of Notch Receptors in Hematologic Malignancies
por: Gragnani, Laura, et al.
Publicado: (2020)

Roles of circRNAs in hematological malignancies
por: Deng, Fahua, et al.
Publicado: (2022)

Invasive Trichosporonosis in Neonates and Pediatric Patients with Malignancies or Hematologic Disorders
por: Kourti, Maria, et al.
Publicado: (2022)

Carbamazepine and Hematological Malignancies
por: Yavaşoğlu, İrfan, et al.
Publicado: (2013)

Malignant benign hematology
por: Sholzberg, Michelle
Publicado: (2018)

Neoantigens in Hematologic Malignancies
por: Biernacki, Melinda A., et al.
Publicado: (2020)

Deubiquitinases in hematological malignancies
por: Lei, Hu, et al.
Publicado: (2021)

Autophagy in Hematological Malignancies
por: García Ruiz, Olga, et al.
Publicado: (2022)

CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies
por: Testa, Ugo, et al.
Publicado: (2014)

Population Pharmacokinetics of Brentuximab Vedotin in Patients With CD30‐Expressing Hematologic Malignancies
por: Li, Hong, et al.
Publicado: (2017)

CD47-targeting antibodies as a novel therapeutic strategy in hematologic malignancies
por: Sun, Jennifer, et al.
Publicado: (2021)

Anti-BP180 Autoantibodies Are Present in Stroke and Recognize Human Cutaneous BP180 and BP180-NC16A
por: Wang, Yanan, et al.
Publicado: (2019)

Human CD180 Transmits Signals via the PIM-1L Kinase
por: Egli, Nicole, et al.
Publicado: (2015)

Pros and Cons of the Cannabinoid System in Cancer: Focus on Hematological Malignancies
por: Irrera, Natasha, et al.
Publicado: (2021)

FAIR Magnet in 180
por: Ordan, Julien
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9amrvoita2sufi44oa8b5budcd